Empress Medical

Seeking 3 million to secure FDA approval and commercialization followed by an exit with a novel treatment for uterine fibroids.

Facebook Twitter LinkedIn

Empress Medical is an early stage women’s health company that has developed a novel treatment for uterine fibroids. Using a heat free suture approach to shrink the fibroid up to 60% to allow for better patient outcome and preserves fertility in women who are still wish to become pregnant.  Invented  by Interventional Radiologist from Yale, Dr. Michael Tal.  Dr. Tal is known for his expertise in uterine fibroids and treatment. Dr. Tal also has a long track record of inventing novel devices that result in an acquisition. These devices are still being used in the medical world today. The executive team has been long standing and has been a part of every technology that has been acquired. The Medical Advisory board  holds the most esteemed professionals in the industry. 

Ready to Ask For Funding for your company?

Post a Funding Request

Empress Medical is no longer seeking funding.